Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Immunogenicity“
Suchtreffer
Begriffe & Kennungen
Empliciti · 4.8 · Immunogenicity As with all therapeutic proteins, there is a potential for immunogenicity to Empliciti. Of 390
Eintrag öffnenEnhertu · 4.8 · As with all therapeutic proteins, there is a potential for immunogenicity. Across 5.4 mg/kg and 6.4 mg/kg dose
Eintrag öffnenEnhertu · 4.8 · Immunogenicity
Eintrag öffnenEnjaymo · 4.8 · 7 Immunogenicity
Eintrag öffnenEnjaymo · 4.8 · Immunogenicity of sutimlimab was assessed in CAD patients in the CARDINAL and CADENZA studies at baseline, dur
Eintrag öffnenEnrylaze · 4.8 · As with all therapeutic proteins, there is a potential for immunogenicity. Immunogenicity assays are highly de
Eintrag öffnenEnrylaze · 4.8 · Immunogenicity It has been reported that there is no to little cross reactivity between crisantaspase and othe
Eintrag öffnenEvenity · 4.8 · Immunogenicity Draft
Eintrag öffnenEydenzelt · 4.8 · As with all therapeutic proteins, there is a potential for immunogenicity with Eydenzelt.
Eintrag öffnenEydenzelt · 4.8 · As with all therapeutic proteins, there is a potential for immunogenicity with Eydenzelt.
Eintrag öffnenEylea · 4.8 · As with all therapeutic proteins, there is a potential for immunogenicity with Eylea.
Eintrag öffnenEylea · 4.8 · As with all therapeutic proteins, there is a potential for immunogenicity with Eylea.
Eintrag öffnenEyluxvi · 4.8 · As with all therapeutic proteins, there is a potential for immunogenicity with Eyluxvi.
Eintrag öffnenFirazyr · 4.8 · Immunogenicity
Eintrag öffnenFlixabi · 4.8 · Immunogenicity Antibodies to infliximab developed in 38% of patients receiving 3 mg/kg compared with 12% of pa
Eintrag öffnenFlixabi · 4.8 · Immunogenicity Antibodies to infliximab were detected in 3 (2.9%) paediatric patients.
Eintrag öffnenFlixabi · 4.8 · Immunogenicity Antibodies to infliximab were detected in 4 (7.7%) patients through week 54.
Eintrag öffnenFlixabi · 4.8 · Immunogenicity Patients who developed antibodies to infliximab were more likely (approximately 2-3 fold) to de
Eintrag öffnenGardasil 9 · 4.5 · Safety and immunogenicity in individuals who have received immunoglobulin or blood-derived products during the
Eintrag öffnenHemgenix · 4.8 · Immunogenicity In the clinical studies with etranacogene dezaparvovec, no Factor IX inhibitor development was
Eintrag öffnen